Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 11 of 11 for “"High dose methotrexate"”.
-
Aspects on optimisation of High Dose Methotrexate treatment in children with Acute Lymphoblastic Leukaemia
… in other malignancies have been developed. Methotrexate is a major component of most contemporary childhood ALL treatment protocols. The main objectives of this thesis were to investigate how methotrexate concentration time data from high dose methotrexate intravenous infusions relate to …
-
High-dose methotrexate for the prevention of central nervous system relapse in diffuse large B-cell lymphoma
Abstracts available at each chapter.
-
Didelių dozių metotreksato uždelsto išsiskyrimo iš organizmo rizikos veiksniai /
Methotrexate is an antimetabolite, structurally similar to folic acid. Methotrexate interferes with purine and pyrimidine synthesis thus killing the cell. Folinic acid has to be co-administered when treating patients with methotrexate. Methotrexate is widely used to treat oncological and autoimmune …
-
Modeliu grindžiamas didelės dozės metotreksato eliminacijos iš organizmo palyginimas prieš ir po standartizuoto didelės dozės metotreksato lašinimo protokolo įgyvendinimo gydant vaikų leukemiją /
High-dose methotrexate is widely used in the treatment of pediatric leukemia. However, its pharmacokinetics shows considerable variability between patients, making it difficult to predict drug elimination and potential delays. To ensure treatment efficacy and reduce the risk of toxicity, it is …
-
Burkitt and Burkitt-like lymphoma/leukaemia at Groote Schuur Hospital from 2005 to 2014: a retrospective review
Introduction: South Africa has the highest global burden of human immunodeficiency virus (HIV). The HIV seropositive population is at increased risk of developing non-Hodgkin lymphoma, particularly high grade aggressive subtypes such as Burkitt- and Burkittlike lymphoma (also known as B-cell …
-
Sequentielle Gabe von Hochdosismethotrexat- und Hochdosiscytarabin-basierter Polychemotherapie bei älteren Patienten mit primärem ZNS-Lymphom
… an analysis of a sequential administration of high-dose methotrexate (HDMTX) - and high-dose cytarabine (HDAraC) - based chemotherapy in PCNSL patients ≥ 65 years at two German centers (University Hospitals Berlin and Bochum). Materials and Methods: A total of 54 consecutive immunocompetent …
-
Deep phenotyping and genotyping of chemotherapy-associated neurotoxicity in children on ALL therapy
… showed recurrence, Down syndrome, Capizzi methotrexate, Single intrathecal methotrexate, and late leucovorin rescue was associated with an increased risk of seizures compared to the rest of the neurotoxicity cohort. Deep phenotyping of PRES cases showed younger age group (< 10 years), …
-
Prognosefaktoren und Prognosepunktwertsysteme für Akuttoxizitäten der Hochdosis-Methotrexat-Therapie bei Patienten mit primären Lymphomen des zentralen Nervensystems
Hochdosis-Methotrexat (HD-MTX) gilt als wirksamste Primärtherapieoption primärer Lymphome des zentralen Nervensystems (PCNSL). Oftmals treten in diesem Kontext potenziell prognoselimitierende schwere Akuttoxizitäten auf. Es wurden jedoch noch keine Prognosefaktoren etabliert, mit denen eine …
-
Hochdosismethotrexat-basierte Polychemotherapie gefolgt von zwei verschiedenen Konsolidierungen bei jüngeren Patienten mit primärem ZNS-Lymphom
Als Standardbehandlung bei jüngeren Patienten mit primärem Lymphom des zentralen Nervensystems (PZNSL) wird heutzutage das Konzept der Konsolidierung einer initia-len Hochdosis Methotrexat (HD-MTX)-basierten Induktionstherapie mit einer Radiothe-rapie, einer nicht kreuzresistenten konventionellen …
-
Establishment and characterisation of chemoresistant osteosarcoma cell lines by single and multi-agent induced strategies
… The combination of cisplatin, doxorubicin and high-dose methotrexate is the standard treatment for most patients. Surgery combined with chemotherapy has improved the survival rate for osteosarcoma patients to 60% - 70%. However, most of the patients with metastatic or recurrent osteosarcoma …
-
Η επίδοση των υψηλών δόσεων μεθοτρεξάτης στη νεφρική λειτουργία παιδιών με οξεία λεμφοβλαστική λευχαιμία
… as an antineoplastic agent. The induction of high dose MTX in many chemotherapeutic protocols of children with ALL has been associated with an important reduction in CNS relapses and an increase of overall survival in those patients. One of the most important side effects of HDMTX is …